Price Controls To Come Into Effect In 2012

BMI View: While it is clear that the implementation of a medicine pricing policy will work towards controlling public pharmaceuticals and healthcare expenditure, we believe that it is vital that the Sri Lankan government implements a policy that acknowledges the operating environment for multinational drug companies selling their products in Sri Lanka (particularly as the country is heavily reliant on foreign produced medicines) and retains a business environment that is attractive to multinational drugmakers - therefore ensuring patient access to innovative medicines.

To read the full article, please choose one of the following options: